Gain Therapeutics, Inc. (GANX) Earnings
|
Expand Research on GANX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +21.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.7% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/26  |
Q425 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | -$0.15 | -$0.15 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 8/12/25 |
Q225 | -$0.19 | -$0.17 | -$0.02 | N/A | N/A | N/A | | | Details | |
| 8/7/25 |
Q225 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/14/25 |
Q125 | N/A | -$0.19 | N/A | N/A | $25K | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | N/A | -$0.19 | N/A | N/A | $25K | N/A | N/A | N/A |
